The COAG and EU-PACT Trials: What is the Clinical Benefit of Pharmacogenetic-Guided Coumarin Dosing During Therapy Inititiation?

E.V. Baranova, F.W. Asselbergs, A. de Boer, A.H. Maitland-van der Zee

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The COAG and EU-PACT Trials: What is the Clinical Benefit of Pharmacogenetic-Guided Coumarin Dosing During Therapy Inititiation?'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science